rs181843638
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001190787.3(MCIDAS):c.821G>A(p.Gly274Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000606 in 1,536,024 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001190787.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCIDAS | NM_001190787.3 | c.821G>A | p.Gly274Glu | missense_variant | 7/7 | ENST00000513312.3 | NP_001177716.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCIDAS | ENST00000513312.3 | c.821G>A | p.Gly274Glu | missense_variant | 7/7 | 1 | NM_001190787.3 | ENSP00000426359 | P1 | |
MCIDAS | ENST00000513468.5 | c.*285G>A | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 5 | ENSP00000422165 |
Frequencies
GnomAD3 genomes AF: 0.00125 AC: 191AN: 152250Hom.: 1 Cov.: 34
GnomAD3 exomes AF: 0.00386 AC: 519AN: 134590Hom.: 8 AF XY: 0.00271 AC XY: 199AN XY: 73304
GnomAD4 exome AF: 0.000536 AC: 741AN: 1383656Hom.: 9 Cov.: 35 AF XY: 0.000451 AC XY: 308AN XY: 682756
GnomAD4 genome AF: 0.00125 AC: 190AN: 152368Hom.: 1 Cov.: 34 AF XY: 0.00136 AC XY: 101AN XY: 74512
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Ciliary dyskinesia, primary, 42 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 09, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at